BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19095009)

  • 1. Isolation of RNA from cell lines and cervical cytology specimens stored in BD SurePath preservative fluid and downstream detection of housekeeping gene and HPV E6 expression using real time RT-PCR.
    Murphy PG; Henderson DT; Adams MD; Horlick EA; Dixon EP; King LM; Avissar PL; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2009 Mar; 156(1-2):138-44. PubMed ID: 19095009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of RNA from residual BD SurePath liquid-based cytology specimens and detection of HPV E6/E7 mRNA using the PreTectt HPV-Proofer assay.
    Dixon EP; King LM; Adams MD; Grønn P; Murphy PG; Brown CA; Brough GH; Skomedal H; Malinowski DP; Fischer TJ
    J Virol Methods; 2008 Dec; 154(1-2):220-2. PubMed ID: 18761379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovery of DNA from BD SurePath cytology specimens and compatibility with the Roche AMPLICOR Human Papillomavirus (HPV) Test.
    Dixon EP; Lenz KL; Doobay H; Brown CA; Malinowski DP; Fischer TJ
    J Clin Virol; 2010 May; 48(1):31-5. PubMed ID: 20233675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical performance of RNA isolated from BD SurePath™ cervical cytology specimens by the PreTect™ HPV-Proofer assay.
    Dixon EP; Grønn P; King LM; Passineau H; Doobay H; Skomedal H; Hariri J; Hay SN; Brown CA; Fischer TJ; Malinowski DP
    J Virol Methods; 2012 Nov; 185(2):199-203. PubMed ID: 22820075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental studies of using real-time fluorescence quantitative PCR and RT-PCR to detect E6 and E7 genes of human papillomavirus type 16 in cervical carcinoma cell lines].
    Chen YY; Peng ZL; Liu SL; He B; Hu M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):443-6. PubMed ID: 17593827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion.
    Cricca M; Venturoli S; Leo E; Costa S; Musiani M; Zerbini M
    J Med Virol; 2009 Jul; 81(7):1276-82. PubMed ID: 19475620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y; Peng ZL; Lou JY; Wang H
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
    Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
    Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of human papillomavirus mRNA detection over time in cervical specimens collected in liquid based cytology medium.
    Cuschieri KS; Beattie G; Hassan S; Robertson K; Cubie H
    J Virol Methods; 2005 Mar; 124(1-2):211-5. PubMed ID: 15664071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
    Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and genotyping analysis of human papillomavirus isolates from liquid-based cervical cytology specimens.
    Avissar P; Malinowski DP
    Methods Mol Biol; 2009; 511():361-70. PubMed ID: 19347306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fixation on RNA integrity in a liquid-based cervical cytology setting.
    Horvath CA; Boulet G; Sahebali S; Depuydt C; Vermeulen T; Vanden Broeck D; Vereecken A; Bogers J
    J Clin Pathol; 2008 Jan; 61(1):132-7. PubMed ID: 17468293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NucliSENS EasyQ HPV v1 test - Testing for oncogenic activity of human papillomaviruses.
    Jeantet D; Schwarzmann F; Tromp J; Melchers WJ; van der Wurff AA; Oosterlaken T; Jacobs M; Troesch A
    J Clin Virol; 2009 Jul; 45 Suppl 1():S29-37. PubMed ID: 19651366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR.
    Marks M; Gupta SB; Liaw KL; Kim E; Tadesse A; Coutlee F; Sriplienchan S; Celentano DD; Gravitt PE
    J Virol Methods; 2009 Mar; 156(1-2):152-6. PubMed ID: 19022296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological study in Tunisian cervical cancer patients.
    Achour M; Kochbati L; Zeghal D; Kahla S; Maalej M; Zouari F; Oueslati R
    Pathol Biol (Paris); 2009 Jul; 57(5):415-9. PubMed ID: 18586408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.